> top > docs > PMC:3359311 > spans > 14047-15230 > annotations

PMC:3359311 / 14047-15230 JSONTXT

Annnotations TAB JSON ListView MergeView

bionlp-st-ge-2016-uniprot

Id Subject Object Predicate Lexical cue
T14169 87-92 P01584 denotes IL-1β
T14170 392-396 P05412 denotes AP-1
T14171 411-415 P10145 denotes IL-8
T14172 425-430 P01584 denotes IL-1β
T14173 673-677 P05412 denotes AP-1
T14174 692-696 P10145 denotes IL-8
T14175 706-711 P01584 denotes IL-1β
T14176 973-978 P01584 denotes IL-1β
T14177 987-991 P10145 denotes IL-8

bionlp-st-ge-2016-reference

Id Subject Object Predicate Lexical cue Speculation
T13923 61-72 Positive_regulation denotes potentiates
T13924 61-72 Positive_regulation denotes potentiates
T13925 87-92 Protein denotes IL-1β
T13926 93-103 Gene_expression denotes production
T13927 108-117 Localization denotes secretion
T13928 118-122 Positive_regulation denotes upon
T13929 118-122 Positive_regulation denotes upon
T13930 425-430 Protein denotes IL-1β
T13931 431-440 Localization denotes secretion
T13932 706-711 Protein denotes IL-1β
T13933 712-721 Localization denotes secretion true
T13934 973-978 Protein denotes IL-1β
R12352 T13923 T13929 themeOf potentiates,upon
R12353 T13924 T13928 themeOf potentiates,upon
R12354 T13925 T13926 themeOf IL-1β,production
R12355 T13925 T13927 themeOf IL-1β,secretion
R12356 T13926 T13924 themeOf production,potentiates
R12357 T13927 T13923 themeOf secretion,potentiates
R12358 T13930 T13931 themeOf IL-1β,secretion
R12359 T13932 T13933 themeOf IL-1β,secretion

bionlp-st-ge-2016-reference-tees

Id Subject Object Predicate Lexical cue
T14485 44-49 Protein denotes NF-κB
T14486 87-92 Protein denotes IL-1β
T14487 50-60 Positive_regulation denotes activation
T14488 93-103 Gene_expression denotes production
T14489 77-83 Negative_regulation denotes degree
T14490 61-72 Positive_regulation denotes potentiates
T14491 389-391 Protein denotes κB
T14492 392-396 Protein denotes AP-1
T14493 602-606 Protein denotes PAO1
T14494 615-619 Protein denotes PAO1
T14495 670-672 Protein denotes κB
T14496 673-677 Protein denotes AP-1
T14497 706-711 Protein denotes IL-1β
T14498 712-721 Localization denotes secretion
T14499 712-721 Localization denotes secretion
T14500 877-881 Protein denotes PAO1
T14501 973-978 Protein denotes IL-1β
R12872 T14485 T14487 themeOf NF-κB,activation
R12873 T14486 T14488 themeOf IL-1β,production
R12874 T14487 T14490 causeOf activation,potentiates
R12875 T14488 T14489 themeOf production,degree
R12876 T14489 T14490 themeOf degree,potentiates
R12877 T14495 T14498 themeOf κB,secretion
R12878 T14497 T14499 themeOf IL-1β,secretion

events-check-again

Id Subject Object Predicate Lexical cue Speculation
T14473 61-72 Positive_regulation denotes potentiates
T14474 61-72 Positive_regulation denotes potentiates
T14475 87-92 Protein denotes IL-1β
T14476 93-103 Gene_expression denotes production
T14477 108-117 Localization denotes secretion
T14478 118-122 Positive_regulation denotes upon
T14479 118-122 Positive_regulation denotes upon
T14480 425-430 Protein denotes IL-1β
T14481 431-440 Localization denotes secretion
T14482 706-711 Protein denotes IL-1β
T14483 712-721 Localization denotes secretion true
T14484 973-978 Protein denotes IL-1β
R12864 T14473 T14479 themeOf potentiates,upon
R12865 T14474 T14478 themeOf potentiates,upon
R12866 T14475 T14476 themeOf IL-1β,production
R12867 T14475 T14477 themeOf IL-1β,secretion
R12868 T14476 T14474 themeOf production,potentiates
R12869 T14477 T14473 themeOf secretion,potentiates
R12870 T14480 T14481 themeOf IL-1β,secretion
R12871 T14482 T14483 themeOf IL-1β,secretion

GO-CC

Id Subject Object Predicate Lexical cue
T14444 163-168 http://purl.obolibrary.org/obo/GO_0005623 denotes cells
T14445 514-519 http://purl.obolibrary.org/obo/GO_0005623 denotes cells

GO-MF

Id Subject Object Predicate Lexical cue
T14446 411-415 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8
T14447 692-696 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8
T14448 987-991 http://purl.obolibrary.org/obo/GO_0005153 denotes IL-8

GO-BP

Id Subject Object Predicate Lexical cue
T14441 108-117 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T14442 431-440 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion
T14443 712-721 http://purl.obolibrary.org/obo/GO_0046903 denotes secretion

bionlp-st-ge-2016-spacy-parsed

Id Subject Object Predicate Lexical cue
T14178 44-49 JJ denotes NF-κB
T14179 50-60 NN denotes activation
T14180 61-72 VBZ denotes potentiates
T14181 73-76 DT denotes the
T14182 77-83 NN denotes degree
T14183 84-86 IN denotes of
T14184 87-92 JJ denotes IL-1β
T14185 93-103 NN denotes production
T14186 104-107 CC denotes and
T14187 108-117 NN denotes secretion
T14188 118-122 IN denotes upon
T14189 123-135 JJ denotes inflammasome
T14190 136-146 NN denotes activation
T14191 146-147 . denotes .
T14192 148-153 CD denotes THP-1
T14193 154-162 NN denotes reporter
T14194 163-168 NNS denotes cells
T14195 169-173 VBD denotes were
T14196 174-180 VBN denotes primed
T14197 181-190 JJ denotes overnight
T14198 191-195 IN denotes with
T14199 196-207 JJ denotes heat-killed
T14200 208-210 NNP denotes P.
T14201 211-221 NN denotes aeruginosa
T14202 222-225 CC denotes and
T14203 226-236 VBD denotes stimulated
T14204 237-240 DT denotes the
T14205 241-245 JJ denotes next
T14206 246-249 NN denotes day
T14207 250-254 IN denotes with
T14208 255-259 JJ denotes live
T14209 260-262 NNP denotes P.
T14210 263-273 NN denotes aeruginosa
T14211 274-276 CC denotes or
T14212 277-287 JJ denotes additional
T14213 288-299 JJ denotes heat-killed
T14214 300-302 NNP denotes P.
T14215 303-313 NN denotes aeruginosa
T14216 314-317 IN denotes for
T14217 318-321 DT denotes the
T14218 322-327 NNS denotes times
T14219 328-337 VBD denotes indicated
T14220 337-338 . denotes .
T14221 339-343 NNP denotes Cell
T14222 344-351 NN denotes culture
T14223 352-364 NNS denotes supernatants
T14224 365-369 VBD denotes were
T14225 370-377 VBN denotes assayed
T14226 378-381 IN denotes for
T14227 382-383 -LRB- denotes (
T14228 383-384 NN denotes A
T14229 384-385 -RRB- denotes )
T14230 386-391 NN denotes NF-κB
T14231 391-392 NN denotes /
T14232 392-396 NN denotes AP-1
T14233 397-405 NN denotes activity
T14234 405-406 , denotes ,
T14235 407-408 -LRB- denotes (
T14236 408-409 NNP denotes B
T14237 409-410 -RRB- denotes )
T14238 411-415 NN denotes IL-8
T14239 415-416 , denotes ,
T14240 417-420 CC denotes and
T14241 421-422 -LRB- denotes (
T14242 422-423 NNP denotes C
T14243 423-424 -RRB- denotes )
T14244 425-430 JJ denotes IL-1β
T14245 431-440 NN denotes secretion
T14246 441-442 -LRB- denotes (
T14247 442-443 FW denotes n
T14248 444-445 SYM denotes =
T14249 446-447 CD denotes 3
T14250 448-449 CD denotes 6
T14251 450-461 NNS denotes experiments
T14252 461-462 -RRB- denotes )
T14253 462-463 . denotes .
T14254 464-469 VBG denotes Using
T14255 470-473 DT denotes the
T14256 474-478 JJ denotes same
T14257 479-490 NN denotes stimulation
T14258 491-497 NN denotes method
T14259 497-498 , denotes ,
T14260 499-504 CD denotes THP-1
T14261 505-513 NN denotes reporter
T14262 514-519 NNS denotes cells
T14263 520-524 VBD denotes were
T14264 525-532 VBN denotes treated
T14265 533-537 IN denotes with
T14266 538-548 NN denotes Bay11-7082
T14267 549-550 -LRB- denotes (
T14268 550-552 CD denotes 20
T14269 553-555 NNP denotes µM
T14270 555-556 -RRB- denotes )
T14271 557-560 IN denotes for
T14272 561-562 CD denotes 1
T14273 563-567 NN denotes hour
T14274 568-573 RB denotes prior
T14275 574-576 TO denotes to
T14276 577-584 VBG denotes priming
T14277 585-589 IN denotes with
T14278 590-601 JJ denotes heat-killed
T14279 602-606 NNP denotes PAO1
T14280 607-609 CC denotes or
T14281 610-614 JJ denotes live
T14282 615-619 NN denotes PAO1
T14283 619-620 . denotes .
T14284 621-633 NNS denotes Supernatants
T14285 634-638 VBD denotes were
T14286 639-646 VBN denotes assayed
T14287 647-649 IN denotes at
T14288 650-652 CD denotes 24
T14289 653-658 NNS denotes hours
T14290 659-662 IN denotes for
T14291 663-664 -LRB- denotes (
T14292 664-665 NNP denotes D
T14293 665-666 -RRB- denotes )
T14294 667-672 NNP denotes NF-κB
T14295 672-673 NNP denotes /
T14296 673-677 NNP denotes AP-1
T14297 678-686 NN denotes activity
T14298 686-687 , denotes ,
T14299 688-689 -LRB- denotes (
T14300 689-690 NNP denotes E
T14301 690-691 -RRB- denotes )
T14302 692-696 NN denotes IL-8
T14303 696-697 , denotes ,
T14304 698-701 CC denotes and
T14305 702-703 -LRB- denotes (
T14306 703-704 NN denotes F
T14307 704-705 -RRB- denotes )
T14308 706-711 NN denotes IL-1β
T14309 712-721 NN denotes secretion
T14310 722-723 -LRB- denotes (
T14311 723-724 FW denotes n
T14312 725-726 SYM denotes =
T14313 727-728 CD denotes 3
T14314 729-730 LS denotes 5
T14315 730-731 -RRB- denotes )
T14316 731-732 . denotes .
T14317 733-738 NNS denotes PBMCs
T14318 739-743 IN denotes from
T14319 744-746 NNP denotes CF
T14320 747-755 NNS denotes patients
T14321 756-757 -LRB- denotes (
T14322 757-758 FW denotes n
T14323 759-760 SYM denotes =
T14324 761-763 CD denotes 11
T14325 764-766 CD denotes 15
T14326 766-767 -RRB- denotes )
T14327 768-771 CC denotes and
T14328 772-780 NNS denotes controls
T14329 781-782 -LRB- denotes (
T14330 782-783 FW denotes n
T14331 784-785 SYM denotes =
T14332 786-788 CD denotes 10
T14333 789-791 CD denotes 13
T14334 791-792 -RRB- denotes )
T14335 793-797 VBD denotes were
T14336 798-805 VBN denotes treated
T14337 806-810 IN denotes with
T14338 811-821 NNP denotes z-YVAD-fmk
T14339 822-823 -LRB- denotes (
T14340 823-825 CD denotes 20
T14341 826-828 NNP denotes µM
T14342 828-829 -RRB- denotes )
T14343 830-832 CC denotes or
T14344 833-843 NN denotes Bay11-7082
T14345 844-845 -LRB- denotes (
T14346 845-847 CD denotes 10
T14347 848-850 NNP denotes µM
T14348 850-851 -RRB- denotes )
T14349 852-855 CC denotes and
T14350 856-866 VBN denotes stimulated
T14351 867-871 IN denotes with
T14352 872-876 JJ denotes live
T14353 877-881 NNP denotes PAO1
T14354 882-883 -LRB- denotes (
T14355 883-886 NNP denotes MOI
T14356 887-888 SYM denotes =
T14357 889-890 LS denotes 1
T14358 890-891 -RRB- denotes )
T14359 891-892 , denotes ,
T14360 893-896 NNP denotes ATP
T14361 897-898 -LRB- denotes (
T14362 898-899 CD denotes 5
T14363 900-902 NNP denotes mM
T14364 902-903 -RRB- denotes )
T14365 903-904 , denotes ,
T14366 905-907 CC denotes or
T14367 908-912 NNP denotes Poly
T14368 912-913 -LRB- denotes (
T14369 913-915 NNP denotes dA
T14370 915-916 : denotes :
T14371 916-918 NN denotes dT
T14372 918-919 -RRB- denotes )
T14373 920-921 -LRB- denotes (
T14374 921-922 CD denotes 1
T14375 923-925 NN denotes µg
T14376 925-926 NN denotes /
T14377 926-928 NN denotes ml
T14378 928-929 -RRB- denotes )
T14379 930-939 VBG denotes according
T14380 940-942 TO denotes to
T14381 943-946 DT denotes the
T14382 947-955 NN denotes schedule
T14383 956-958 IN denotes in
T14384 959-965 NN denotes Figure
T14385 966-967 CD denotes 1
T14386 967-968 . denotes .
T14387 969-970 -LRB- denotes (
T14388 970-971 NNP denotes G
T14389 971-972 -RRB- denotes )
T14390 973-978 NN denotes IL-1β
T14391 979-982 CC denotes and
T14392 983-984 -LRB- denotes (
T14393 984-985 NNP denotes H
T14394 985-986 -RRB- denotes )
T14395 987-991 NN denotes IL-8
T14396 992-998 NNS denotes levels
T14397 999-1003 VBD denotes were
T14398 1004-1012 VBN denotes measured
T14399 1013-1015 IN denotes at
T14400 1016-1018 CD denotes 24
T14401 1019-1024 NNS denotes hours
T14402 1024-1025 . denotes .
T14403 1026-1037 NNP denotes Statistical
T14404 1038-1046 NN denotes analysis
T14405 1047-1050 VBD denotes was
T14406 1051-1060 VBN denotes performed
T14407 1061-1066 VBG denotes using
T14408 1067-1070 CD denotes two
T14409 1071-1074 NN denotes way
T14410 1075-1080 NNP denotes ANOVA
T14411 1081-1085 IN denotes with
T14412 1086-1096 NNP denotes Bonferroni
T14413 1097-1107 NN denotes correction
T14414 1108-1111 IN denotes for
T14415 1112-1120 JJ denotes multiple
T14416 1121-1132 NNS denotes comparisons
T14417 1132-1133 . denotes .
T14418 1134-1135 SYM denotes *
T14419 1135-1136 , denotes ,
T14420 1137-1139 SYM denotes **
T14421 1139-1140 , denotes ,
T14422 1141-1144 CC denotes and
T14423 1145-1148 RB denotes ***
T14424 1149-1156 VB denotes signify
T14425 1157-1158 NNP denotes P
T14426 1158-1159 CD denotes <
T14427 1159-1163 CD denotes 0.05
T14428 1163-1164 , denotes ,
T14429 1165-1169 CD denotes 0.01
T14430 1169-1170 , denotes ,
T14431 1171-1174 CC denotes and
T14432 1175-1180 CD denotes 0.001
T14433 1180-1181 . denotes .
R12592 T14178 T14179 amod NF-κB,activation
R12593 T14179 T14180 nsubj activation,potentiates
R12594 T14180 T14180 ROOT potentiates,potentiates
R12595 T14181 T14182 det the,degree
R12596 T14182 T14180 dobj degree,potentiates
R12597 T14183 T14182 prep of,degree
R12598 T14184 T14185 amod IL-1β,production
R12599 T14185 T14183 pobj production,of
R12600 T14186 T14185 cc and,production
R12601 T14187 T14185 conj secretion,production
R12602 T14188 T14185 prep upon,production
R12603 T14189 T14190 amod inflammasome,activation
R12604 T14190 T14188 pobj activation,upon
R12605 T14191 T14180 punct .,potentiates
R12606 T14192 T14194 nummod THP-1,cells
R12607 T14193 T14194 compound reporter,cells
R12608 T14194 T14196 nsubjpass cells,primed
R12609 T14195 T14196 auxpass were,primed
R12610 T14196 T14196 ROOT primed,primed
R12611 T14197 T14196 npadvmod overnight,primed
R12612 T14198 T14197 prep with,overnight
R12613 T14199 T14201 amod heat-killed,aeruginosa
R12614 T14200 T14201 compound P.,aeruginosa
R12615 T14201 T14198 pobj aeruginosa,with
R12616 T14202 T14196 cc and,primed
R12617 T14203 T14196 conj stimulated,primed
R12618 T14204 T14206 det the,day
R12619 T14205 T14206 amod next,day
R12620 T14206 T14203 dobj day,stimulated
R12621 T14207 T14203 prep with,stimulated
R12622 T14208 T14210 amod live,aeruginosa
R12623 T14209 T14210 compound P.,aeruginosa
R12624 T14210 T14207 pobj aeruginosa,with
R12625 T14211 T14210 cc or,aeruginosa
R12626 T14212 T14215 amod additional,aeruginosa
R12627 T14213 T14215 amod heat-killed,aeruginosa
R12628 T14214 T14215 compound P.,aeruginosa
R12629 T14215 T14210 conj aeruginosa,aeruginosa
R12630 T14216 T14215 prep for,aeruginosa
R12631 T14217 T14218 det the,times
R12632 T14218 T14216 pobj times,for
R12633 T14219 T14203 conj indicated,stimulated
R12634 T14220 T14196 punct .,primed
R12635 T14221 T14223 compound Cell,supernatants
R12636 T14222 T14223 compound culture,supernatants
R12637 T14223 T14225 nsubjpass supernatants,assayed
R12638 T14224 T14225 auxpass were,assayed
R12639 T14225 T14225 ROOT assayed,assayed
R12640 T14226 T14225 prep for,assayed
R12641 T14227 T14228 punct (,A
R12642 T14228 T14233 nmod A,activity
R12643 T14229 T14228 punct ),A
R12644 T14230 T14233 nmod NF-κB,activity
R12645 T14231 T14233 nmod /,activity
R12646 T14232 T14233 compound AP-1,activity
R12647 T14233 T14226 pobj activity,for
R12648 T14234 T14233 punct ",",activity
R12649 T14235 T14238 punct (,IL-8
R12650 T14236 T14238 nmod B,IL-8
R12651 T14237 T14236 punct ),B
R12652 T14238 T14233 appos IL-8,activity
R12653 T14239 T14238 punct ",",IL-8
R12654 T14240 T14238 cc and,IL-8
R12655 T14241 T14242 punct (,C
R12656 T14242 T14245 nmod C,secretion
R12657 T14243 T14242 punct ),C
R12658 T14244 T14245 amod IL-1β,secretion
R12659 T14245 T14238 conj secretion,IL-8
R12660 T14246 T14247 punct (,n
R12661 T14247 T14238 conj n,IL-8
R12662 T14248 T14249 punct =,3
R12663 T14249 T14247 prep 3,n
R12664 T14250 T14251 nummod 6,experiments
R12665 T14251 T14249 appos experiments,3
R12701 T14287 T14286 prep at,assayed
R12666 T14252 T14249 punct ),3
R12667 T14253 T14225 punct .,assayed
R12668 T14254 T14264 advcl Using,treated
R12669 T14255 T14258 det the,method
R12670 T14256 T14258 amod same,method
R12671 T14257 T14258 compound stimulation,method
R12672 T14258 T14254 dobj method,Using
R12673 T14259 T14264 punct ",",treated
R12674 T14260 T14262 nummod THP-1,cells
R12675 T14261 T14262 compound reporter,cells
R12676 T14262 T14264 nsubjpass cells,treated
R12677 T14263 T14264 auxpass were,treated
R12678 T14264 T14264 ROOT treated,treated
R12679 T14265 T14264 prep with,treated
R12680 T14266 T14265 pobj Bay11-7082,with
R12681 T14267 T14269 punct (,µM
R12682 T14268 T14269 nummod 20,µM
R12683 T14269 T14266 appos µM,Bay11-7082
R12684 T14270 T14269 punct ),µM
R12685 T14271 T14264 prep for,treated
R12686 T14272 T14273 nummod 1,hour
R12687 T14273 T14271 pobj hour,for
R12688 T14274 T14264 advmod prior,treated
R12689 T14275 T14274 prep to,prior
R12690 T14276 T14275 pobj priming,to
R12691 T14277 T14276 prep with,priming
R12692 T14278 T14279 compound heat-killed,PAO1
R12693 T14279 T14277 pobj PAO1,with
R12694 T14280 T14264 cc or,treated
R12695 T14281 T14264 conj live,treated
R12696 T14282 T14281 npadvmod PAO1,live
R12697 T14283 T14264 punct .,treated
R12698 T14284 T14286 nsubjpass Supernatants,assayed
R12699 T14285 T14286 auxpass were,assayed
R12700 T14286 T14286 ROOT assayed,assayed
R12702 T14288 T14289 nummod 24,hours
R12703 T14289 T14287 pobj hours,at
R12704 T14290 T14286 prep for,assayed
R12705 T14291 T14292 punct (,D
R12706 T14292 T14290 pobj D,for
R12707 T14293 T14292 punct ),D
R12708 T14294 T14296 compound NF-κB,AP-1
R12709 T14295 T14296 compound /,AP-1
R12710 T14296 T14297 compound AP-1,activity
R12711 T14297 T14297 ROOT activity,activity
R12712 T14298 T14297 punct ",",activity
R12713 T14299 T14302 punct (,IL-8
R12714 T14300 T14302 nmod E,IL-8
R12715 T14301 T14302 punct ),IL-8
R12716 T14302 T14309 nmod IL-8,secretion
R12717 T14303 T14302 punct ",",IL-8
R12718 T14304 T14302 cc and,IL-8
R12719 T14305 T14306 punct (,F
R12720 T14306 T14302 conj F,IL-8
R12721 T14307 T14306 punct ),F
R12722 T14308 T14309 compound IL-1β,secretion
R12723 T14309 T14297 appos secretion,activity
R12724 T14310 T14313 punct (,3
R12725 T14311 T14313 advmod n,3
R12726 T14312 T14313 punct =,3
R12727 T14313 T14309 nummod 3,secretion
R12728 T14314 T14336 meta 5,treated
R12729 T14315 T14314 punct ),5
R12730 T14316 T14314 punct .,5
R12731 T14317 T14336 nsubjpass PBMCs,treated
R12732 T14318 T14317 prep from,PBMCs
R12733 T14319 T14320 compound CF,patients
R12734 T14320 T14318 pobj patients,from
R12735 T14321 T14320 punct (,patients
R12736 T14322 T14336 nsubjpass n,treated
R12737 T14323 T14324 punct =,11
R12738 T14324 T14322 prep 11,n
R12739 T14325 T14324 appos 15,11
R12740 T14326 T14324 punct ),11
R12741 T14327 T14322 cc and,n
R12742 T14328 T14322 conj controls,n
R12743 T14329 T14332 punct (,10
R12744 T14330 T14332 advmod n,10
R12745 T14331 T14332 punct =,10
R12746 T14332 T14322 appos 10,n
R12747 T14333 T14332 appos 13,10
R12748 T14334 T14332 punct ),10
R12749 T14335 T14336 auxpass were,treated
R12750 T14336 T14286 advcl treated,assayed
R12751 T14337 T14336 prep with,treated
R12752 T14338 T14337 pobj z-YVAD-fmk,with
R12753 T14339 T14341 punct (,µM
R12754 T14340 T14341 nummod 20,µM
R12755 T14341 T14338 appos µM,z-YVAD-fmk
R12756 T14342 T14341 punct ),µM
R12757 T14343 T14338 cc or,z-YVAD-fmk
R12758 T14344 T14338 conj Bay11-7082,z-YVAD-fmk
R12759 T14345 T14347 punct (,µM
R12760 T14346 T14347 nummod 10,µM
R12761 T14347 T14344 appos µM,Bay11-7082
R12762 T14348 T14347 punct ),µM
R12763 T14349 T14336 cc and,treated
R12764 T14350 T14336 conj stimulated,treated
R12765 T14351 T14350 prep with,stimulated
R12766 T14352 T14353 amod live,PAO1
R12767 T14353 T14351 pobj PAO1,with
R12768 T14354 T14377 punct (,ml
R12769 T14355 T14377 nmod MOI,ml
R12770 T14356 T14357 punct =,1
R12771 T14357 T14355 nummod 1,MOI
R12772 T14358 T14357 punct ),1
R12773 T14359 T14355 punct ",",MOI
R12774 T14360 T14355 conj ATP,MOI
R12775 T14361 T14362 punct (,5
R12776 T14362 T14363 nummod 5,mM
R12777 T14363 T14355 conj mM,MOI
R12778 T14364 T14363 punct ),mM
R12779 T14365 T14355 punct ",",MOI
R12780 T14366 T14355 cc or,MOI
R12781 T14367 T14355 conj Poly,MOI
R12782 T14368 T14367 punct (,Poly
R12783 T14369 T14377 nmod dA,ml
R12784 T14370 T14369 punct :,dA
R12785 T14371 T14369 appos dT,dA
R12786 T14372 T14369 punct ),dA
R12787 T14373 T14377 punct (,ml
R12788 T14374 T14375 nummod 1,µg
R12789 T14375 T14377 nmod µg,ml
R12790 T14376 T14377 compound /,ml
R12791 T14377 T14353 appos ml,PAO1
R12792 T14378 T14377 punct ),ml
R12793 T14379 T14286 prep according,assayed
R12794 T14380 T14379 prep to,according
R12795 T14381 T14382 det the,schedule
R12796 T14382 T14380 pobj schedule,to
R12797 T14383 T14382 prep in,schedule
R12798 T14384 T14383 pobj Figure,in
R12799 T14385 T14384 nummod 1,Figure
R12800 T14386 T14286 punct .,assayed
R12801 T14387 T14390 punct (,IL-1β
R12802 T14388 T14390 nmod G,IL-1β
R12803 T14389 T14390 punct ),IL-1β
R12804 T14390 T14396 nmod IL-1β,levels
R12805 T14391 T14390 cc and,IL-1β
R12806 T14392 T14393 punct (,H
R12807 T14393 T14390 conj H,IL-1β
R12808 T14394 T14393 punct ),H
R12809 T14395 T14396 compound IL-8,levels
R12810 T14396 T14398 nsubjpass levels,measured
R12811 T14397 T14398 auxpass were,measured
R12812 T14398 T14398 ROOT measured,measured
R12813 T14399 T14398 prep at,measured
R12814 T14400 T14401 nummod 24,hours
R12815 T14401 T14399 pobj hours,at
R12816 T14402 T14398 punct .,measured
R12817 T14403 T14404 compound Statistical,analysis
R12818 T14404 T14406 nsubjpass analysis,performed
R12819 T14405 T14406 auxpass was,performed
R12820 T14406 T14406 ROOT performed,performed
R12821 T14407 T14406 advcl using,performed
R12822 T14408 T14409 nummod two,way
R12823 T14409 T14410 advmod way,ANOVA
R12824 T14410 T14407 dobj ANOVA,using
R12825 T14411 T14410 prep with,ANOVA
R12826 T14412 T14413 compound Bonferroni,correction
R12827 T14413 T14411 pobj correction,with
R12828 T14414 T14413 prep for,correction
R12829 T14415 T14416 amod multiple,comparisons
R12830 T14416 T14414 pobj comparisons,for
R12831 T14417 T14406 punct .,performed
R12832 T14418 T14424 punct *,signify
R12833 T14419 T14424 punct ",",signify
R12834 T14420 T14424 nsubj **,signify
R12835 T14421 T14420 punct ",",**
R12836 T14422 T14420 cc and,**
R12837 T14423 T14424 advmod ***,signify
R12838 T14424 T14424 ROOT signify,signify
R12839 T14425 T14424 dobj P,signify
R12840 T14426 T14425 nummod <,P
R12841 T14427 T14425 nummod 0.05,P
R12842 T14428 T14425 punct ",",P
R12843 T14429 T14425 appos 0.01,P
R12844 T14430 T14425 punct ",",P
R12845 T14431 T14425 cc and,P
R12846 T14432 T14425 conj 0.001,P
R12847 T14433 T14424 punct .,signify

pmc-enju-pas

Id Subject Object Predicate Lexical cue
T13942 44-49 NN denotes NF-κB
T13943 50-60 NN denotes activation
T13944 61-72 VB denotes potentiates
T13945 73-76 DT denotes the
T13946 77-83 NN denotes degree
T13947 84-86 IN denotes of
T13948 87-92 NN denotes IL-1β
T13949 93-103 NN denotes production
T13950 104-107 CC denotes and
T13951 108-117 NN denotes secretion
T13952 118-122 IN denotes upon
T13953 123-135 JJ denotes inflammasome
T13954 136-146 NN denotes activation
T13955 148-153 NN denotes THP-1
T13956 154-162 NN denotes reporter
T13957 163-168 NN denotes cells
T13958 169-173 VB denotes were
T13959 174-180 VB denotes primed
T13960 181-190 RB denotes overnight
T13961 191-195 IN denotes with
T13962 196-207 JJ denotes heat-killed
T13963 208-210 NNP denotes P.
T13964 211-221 NN denotes aeruginosa
T13965 222-225 CC denotes and
T13966 226-236 VB denotes stimulated
T13967 237-240 DT denotes the
T13968 241-245 JJ denotes next
T13969 246-249 NN denotes day
T13970 250-254 IN denotes with
T13971 255-259 JJ denotes live
T13972 260-262 NNP denotes P.
T13973 263-273 NN denotes aeruginosa
T13974 274-276 CC denotes or
T13975 277-287 JJ denotes additional
T13976 288-299 JJ denotes heat-killed
T13977 300-302 NNP denotes P.
T13978 303-313 NN denotes aeruginosa
T13979 314-317 IN denotes for
T13980 318-321 DT denotes the
T13981 322-327 NN denotes times
T13982 328-337 VB denotes indicated
T13983 339-343 NN denotes Cell
T13984 344-351 NN denotes culture
T13985 352-364 NN denotes supernatants
T13986 365-369 VB denotes were
T13987 370-377 VB denotes assayed
T13988 378-381 IN denotes for
T13989 382-383 -LRB- denotes (
T13990 383-384 NN denotes A
T13991 384-385 -RRB- denotes )
T13992 386-396 NN denotes NF-κB/AP-1
T13993 397-405 NN denotes activity
T13994 405-406 -COMMA- denotes ,
T13995 407-408 -LRB- denotes (
T13996 408-409 NN denotes B
T13997 409-410 -RRB- denotes )
T13998 411-415 NN denotes IL-8
T13999 415-416 -COMMA- denotes ,
T14000 417-420 CC denotes and
T14001 421-422 -LRB- denotes (
T14002 422-423 NN denotes C
T14003 423-424 -RRB- denotes )
T14004 425-430 NN denotes IL-1β
T14005 431-440 NN denotes secretion
T14006 441-442 -LRB- denotes (
T14007 442-449 NN denotes n = 3–6
T14008 450-461 NN denotes experiments
T14009 461-462 -RRB- denotes )
T14010 464-469 VB denotes Using
T14011 470-473 DT denotes the
T14012 474-478 JJ denotes same
T14013 479-490 NN denotes stimulation
T14014 491-497 NN denotes method
T14015 497-498 -COMMA- denotes ,
T14016 499-504 NN denotes THP-1
T14017 505-513 NN denotes reporter
T14018 514-519 NN denotes cells
T14019 520-524 VB denotes were
T14020 525-532 VB denotes treated
T14021 533-537 IN denotes with
T14022 538-548 NN denotes Bay11-7082
T14023 549-550 -LRB- denotes (
T14024 550-552 CD denotes 20
T14025 553-555 NN denotes µM
T14026 555-556 -RRB- denotes )
T14027 557-560 IN denotes for
T14028 561-562 CD denotes 1
T14029 563-567 NN denotes hour
T14030 568-573 JJ denotes prior
T14031 574-576 TO denotes to
T14032 577-584 NN denotes priming
T14033 585-589 IN denotes with
T14034 590-601 JJ denotes heat-killed
T14035 602-606 NN denotes PAO1
T14036 607-609 CC denotes or
T14037 610-614 JJ denotes live
T14038 615-619 NN denotes PAO1
T14039 621-633 NN denotes Supernatants
T14040 634-638 VB denotes were
T14041 639-646 VB denotes assayed
T14042 647-649 IN denotes at
T14043 650-652 CD denotes 24
T14044 653-658 NN denotes hours
T14045 659-662 IN denotes for
T14046 663-664 -LRB- denotes (
T14047 664-665 NN denotes D
T14048 665-666 -RRB- denotes )
T14049 667-677 NN denotes NF-κB/AP-1
T14050 678-686 NN denotes activity
T14051 686-687 -COMMA- denotes ,
T14052 688-689 -LRB- denotes (
T14053 689-690 NN denotes E
T14054 690-691 -RRB- denotes )
T14055 692-696 NN denotes IL-8
T14056 696-697 -COMMA- denotes ,
T14057 698-701 CC denotes and
T14058 702-703 -LRB- denotes (
T14059 703-704 NN denotes F
T14060 704-705 -RRB- denotes )
T14061 706-711 NN denotes IL-1β
T14062 712-721 NN denotes secretion
T14063 722-723 -LRB- denotes (
T14064 723-730 NN denotes n = 3–5
T14065 730-731 -RRB- denotes )
T14066 733-738 NN denotes PBMCs
T14067 739-743 IN denotes from
T14068 744-746 NN denotes CF
T14069 747-755 NN denotes patients
T14070 756-757 -LRB- denotes (
T14071 757-766 NN denotes n = 11–15
T14072 766-767 -RRB- denotes )
T14073 768-771 CC denotes and
T14074 772-780 NN denotes controls
T14075 781-782 -LRB- denotes (
T14076 782-791 NN denotes n = 10–13
T14077 791-792 -RRB- denotes )
T14078 793-797 VB denotes were
T14079 798-805 VB denotes treated
T14080 806-810 IN denotes with
T14081 811-821 NN denotes z-YVAD-fmk
T14082 822-823 -LRB- denotes (
T14083 823-825 CD denotes 20
T14084 826-828 NN denotes µM
T14085 828-829 -RRB- denotes )
T14086 830-832 CC denotes or
T14087 833-843 NN denotes Bay11-7082
T14088 844-845 -LRB- denotes (
T14089 845-847 CD denotes 10
T14090 848-850 NN denotes µM
T14091 850-851 -RRB- denotes )
T14092 852-855 CC denotes and
T14093 856-866 VB denotes stimulated
T14094 867-871 IN denotes with
T14095 872-876 JJ denotes live
T14096 877-881 NN denotes PAO1
T14097 882-883 -LRB- denotes (
T14098 883-890 NN denotes MOI = 1
T14099 890-891 -RRB- denotes )
T14100 891-892 -COMMA- denotes ,
T14101 893-896 NN denotes ATP
T14102 897-898 -LRB- denotes (
T14103 898-899 CD denotes 5
T14104 900-902 NN denotes mM
T14105 902-903 -RRB- denotes )
T14106 903-904 -COMMA- denotes ,
T14107 905-907 CC denotes or
T14108 908-912 NNP denotes Poly
T14109 912-913 -LRB- denotes (
T14110 913-915 NN denotes dA
T14111 915-916 -COLON- denotes :
T14112 916-918 NN denotes dT
T14113 918-919 -RRB- denotes )
T14114 920-921 -LRB- denotes (
T14115 921-922 CD denotes 1
T14116 923-928 NN denotes µg/ml
T14117 928-929 -RRB- denotes )
T14118 930-939 VB denotes according
T14119 940-942 TO denotes to
T14120 943-946 DT denotes the
T14121 947-955 NN denotes schedule
T14122 956-958 IN denotes in
T14123 959-965 NN denotes Figure
T14124 966-968 CD denotes 1.
T14125 969-970 -LRB- denotes (
T14126 970-971 NN denotes G
T14127 971-972 -RRB- denotes )
T14128 973-978 NN denotes IL-1β
T14129 979-982 CC denotes and
T14130 983-984 -LRB- denotes (
T14131 984-985 NN denotes H
T14132 985-986 -RRB- denotes )
T14133 987-991 NN denotes IL-8
T14134 992-998 NN denotes levels
T14135 999-1003 VB denotes were
T14136 1004-1012 VB denotes measured
T14137 1013-1015 IN denotes at
T14138 1016-1018 CD denotes 24
T14139 1019-1024 NN denotes hours
T14140 1026-1037 JJ denotes Statistical
T14141 1038-1046 NN denotes analysis
T14142 1047-1050 VB denotes was
T14143 1051-1060 VB denotes performed
T14144 1061-1066 VB denotes using
T14145 1067-1070 CD denotes two
T14146 1071-1074 NN denotes way
T14147 1075-1080 NN denotes ANOVA
T14148 1081-1085 IN denotes with
T14149 1086-1096 NNP denotes Bonferroni
T14150 1097-1107 NN denotes correction
T14151 1108-1111 IN denotes for
T14152 1112-1120 JJ denotes multiple
T14153 1121-1133 NN denotes comparisons.
T14154 1134-1135 SYM denotes *
T14155 1135-1136 -COMMA- denotes ,
T14156 1137-1139 SYM denotes **
T14157 1139-1140 -COMMA- denotes ,
T14158 1141-1144 CC denotes and
T14159 1145-1148 SYM denotes ***
T14160 1149-1156 VB denotes signify
T14161 1157-1158 NN denotes P
T14162 1158-1159 SYM denotes <
T14163 1159-1163 CD denotes 0.05
T14164 1163-1164 -COMMA- denotes ,
T14165 1165-1169 CD denotes 0.01
T14166 1169-1170 -COMMA- denotes ,
T14167 1171-1174 CC denotes and
T14168 1175-1180 CD denotes 0.001
R12360 T13943 T13942 arg1Of activation,NF-κB
R12361 T13943 T13944 arg1Of activation,potentiates
R12362 T13946 T13944 arg2Of degree,potentiates
R12363 T13946 T13945 arg1Of degree,the
R12364 T13946 T13947 arg1Of degree,of
R12365 T13946 T13952 arg1Of degree,upon
R12366 T13949 T13950 arg1Of production,and
R12367 T13950 T13947 arg2Of and,of
R12368 T13950 T13948 arg1Of and,IL-1β
R12369 T13951 T13950 arg2Of secretion,and
R12370 T13954 T13952 arg2Of activation,upon
R12371 T13954 T13953 arg1Of activation,inflammasome
R12372 T13957 T13955 arg1Of cells,THP-1
R12373 T13957 T13956 arg1Of cells,reporter
R12374 T13957 T13958 arg1Of cells,were
R12375 T13957 T13959 arg2Of cells,primed
R12376 T13957 T13966 arg1Of cells,stimulated
R12377 T13959 T13958 arg2Of primed,were
R12378 T13959 T13960 arg1Of primed,overnight
R12379 T13959 T13961 arg1Of primed,with
R12380 T13959 T13965 arg1Of primed,and
R12381 T13964 T13961 arg2Of aeruginosa,with
R12382 T13964 T13962 arg1Of aeruginosa,heat-killed
R12383 T13964 T13963 arg1Of aeruginosa,P.
R12384 T13965 T13982 arg2Of and,indicated
R12385 T13966 T13965 arg2Of stimulated,and
R12386 T13966 T13970 arg1Of stimulated,with
R12387 T13969 T13966 arg2Of day,stimulated
R12388 T13969 T13967 arg1Of day,the
R12389 T13969 T13968 arg1Of day,next
R12390 T13973 T13970 arg2Of aeruginosa,with
R12391 T13973 T13971 arg1Of aeruginosa,live
R12392 T13973 T13972 arg1Of aeruginosa,P.
R12393 T13978 T13974 arg1Of aeruginosa,or
R12394 T13978 T13975 arg1Of aeruginosa,additional
R12395 T13978 T13976 arg1Of aeruginosa,heat-killed
R12396 T13978 T13977 arg1Of aeruginosa,P.
R12397 T13978 T13979 arg1Of aeruginosa,for
R12398 T13978 T13982 arg1Of aeruginosa,indicated
R12399 T13981 T13979 arg2Of times,for
R12400 T13981 T13980 arg1Of times,the
R12401 T13985 T13983 arg1Of supernatants,Cell
R12402 T13985 T13984 arg1Of supernatants,culture
R12403 T13985 T13986 arg1Of supernatants,were
R12404 T13985 T13987 arg2Of supernatants,assayed
R12405 T13987 T13986 arg2Of assayed,were
R12406 T13987 T13988 arg1Of assayed,for
R12407 T13990 T13989 arg2Of A,(
R12408 T13991 T13989 arg3Of ),(
R12409 T13993 T13989 arg1Of activity,(
R12410 T13993 T13992 arg1Of activity,NF-κB/AP-1
R12411 T13993 T13994 arg1Of activity,","
R12412 T13994 T14000 arg1Of ",",and
R12413 T13996 T13995 arg2Of B,(
R12414 T13997 T13995 arg3Of ),(
R12415 T13998 T13994 arg2Of IL-8,","
R12416 T13998 T13995 arg1Of IL-8,(
R12417 T14000 T13988 arg2Of and,for
R12418 T14000 T13999 arg1Of and,","
R12419 T14002 T14001 arg2Of C,(
R12420 T14003 T14001 arg3Of ),(
R12421 T14005 T14000 arg2Of secretion,and
R12422 T14005 T14001 arg1Of secretion,(
R12423 T14005 T14004 arg1Of secretion,IL-1β
R12424 T14005 T14006 arg1Of secretion,(
R12425 T14008 T14006 arg2Of experiments,(
R12426 T14008 T14007 arg1Of experiments,n = 3–6
R12427 T14009 T14006 arg3Of ),(
R12428 T14014 T14010 arg2Of method,Using
R12429 T14014 T14011 arg1Of method,the
R12430 T14014 T14012 arg1Of method,same
R12431 T14014 T14013 arg1Of method,stimulation
R12432 T14018 T14016 arg1Of cells,THP-1
R12433 T14018 T14017 arg1Of cells,reporter
R12434 T14018 T14019 arg1Of cells,were
R12435 T14018 T14020 arg2Of cells,treated
R12436 T14020 T14010 modOf treated,Using
R12437 T14020 T14015 arg1Of treated,","
R12438 T14020 T14019 arg2Of treated,were
R12439 T14020 T14021 arg1Of treated,with
R12440 T14020 T14027 arg1Of treated,for
R12441 T14022 T14021 arg2Of Bay11-7082,with
R12442 T14022 T14023 arg1Of Bay11-7082,(
R12443 T14025 T14023 arg2Of µM,(
R12444 T14025 T14024 arg1Of µM,20
R12445 T14026 T14023 arg3Of ),(
R12446 T14029 T14027 arg2Of hour,for
R12447 T14029 T14028 arg1Of hour,1
R12448 T14029 T14030 arg1Of hour,prior
R12449 T14030 T14031 arg1Of prior,to
R12450 T14032 T14031 arg2Of priming,to
R12451 T14032 T14033 arg1Of priming,with
R12452 T14035 T14034 arg1Of PAO1,heat-killed
R12453 T14035 T14036 arg1Of PAO1,or
R12454 T14036 T14033 arg2Of or,with
R12455 T14038 T14036 arg2Of PAO1,or
R12456 T14038 T14037 arg1Of PAO1,live
R12457 T14039 T14040 arg1Of Supernatants,were
R12458 T14039 T14041 arg2Of Supernatants,assayed
R12459 T14041 T14040 arg2Of assayed,were
R12460 T14041 T14042 arg1Of assayed,at
R12461 T14041 T14045 arg1Of assayed,for
R12462 T14044 T14042 arg2Of hours,at
R12463 T14044 T14043 arg1Of hours,24
R12464 T14047 T14046 arg2Of D,(
R12465 T14048 T14046 arg3Of ),(
R12466 T14050 T14046 arg1Of activity,(
R12467 T14050 T14049 arg1Of activity,NF-κB/AP-1
R12468 T14050 T14051 arg1Of activity,","
R12469 T14051 T14057 arg1Of ",",and
R12470 T14053 T14052 arg2Of E,(
R12471 T14054 T14052 arg3Of ),(
R12472 T14055 T14051 arg2Of IL-8,","
R12473 T14055 T14052 arg1Of IL-8,(
R12474 T14057 T14045 arg2Of and,for
R12475 T14057 T14056 arg1Of and,","
R12476 T14059 T14058 arg2Of F,(
R12477 T14060 T14058 arg3Of ),(
R12478 T14062 T14057 arg2Of secretion,and
R12479 T14062 T14058 arg1Of secretion,(
R12480 T14062 T14061 arg1Of secretion,IL-1β
R12481 T14062 T14063 arg1Of secretion,(
R12482 T14064 T14063 arg2Of n = 3–5,(
R12483 T14065 T14063 arg3Of ),(
R12484 T14066 T14067 arg1Of PBMCs,from
R12485 T14066 T14078 arg1Of PBMCs,were
R12486 T14066 T14079 arg2Of PBMCs,treated
R12487 T14066 T14093 arg2Of PBMCs,stimulated
R12488 T14069 T14068 arg1Of patients,CF
R12489 T14069 T14070 arg1Of patients,(
R12490 T14069 T14073 arg1Of patients,and
R12491 T14071 T14070 arg2Of n = 11–15,(
R12492 T14072 T14070 arg3Of ),(
R12493 T14073 T14067 arg2Of and,from
R12494 T14074 T14073 arg2Of controls,and
R12495 T14074 T14075 arg1Of controls,(
R12496 T14076 T14075 arg2Of n = 10–13,(
R12497 T14077 T14075 arg3Of ),(
R12498 T14079 T14080 arg1Of treated,with
R12499 T14079 T14092 arg1Of treated,and
R12500 T14081 T14082 arg1Of z-YVAD-fmk,(
R12501 T14081 T14086 arg1Of z-YVAD-fmk,or
R12502 T14084 T14082 arg2Of µM,(
R12503 T14084 T14083 arg1Of µM,20
R12504 T14085 T14082 arg3Of ),(
R12505 T14086 T14080 arg2Of or,with
R12506 T14087 T14086 arg2Of Bay11-7082,or
R12507 T14087 T14088 arg1Of Bay11-7082,(
R12508 T14090 T14088 arg2Of µM,(
R12509 T14090 T14089 arg1Of µM,10
R12510 T14091 T14088 arg3Of ),(
R12511 T14092 T14078 arg2Of and,were
R12512 T14092 T14118 arg1Of and,according
R12513 T14092 T14129 arg1Of and,and
R12514 T14093 T14092 arg2Of stimulated,and
R12515 T14093 T14094 arg1Of stimulated,with
R12516 T14096 T14095 arg1Of PAO1,live
R12517 T14096 T14097 arg1Of PAO1,(
R12518 T14096 T14100 arg1Of PAO1,","
R12519 T14098 T14097 arg2Of MOI = 1,(
R12520 T14099 T14097 arg3Of ),(
R12521 T14100 T14107 arg1Of ",",or
R12522 T14101 T14100 arg2Of ATP,","
R12523 T14101 T14102 arg1Of ATP,(
R12524 T14104 T14102 arg2Of mM,(
R12525 T14104 T14103 arg1Of mM,5
R12526 T14105 T14102 arg3Of ),(
R12527 T14107 T14094 arg2Of or,with
R12528 T14107 T14106 arg1Of or,","
R12529 T14108 T14107 arg2Of Poly,or
R12530 T14108 T14109 arg1Of Poly,(
R12531 T14108 T14114 arg1Of Poly,(
R12532 T14110 T14109 arg2Of dA,(
R12533 T14110 T14111 arg1Of dA,:
R12534 T14110 T14112 arg1Of dA,dT
R12535 T14113 T14109 arg3Of ),(
R12536 T14116 T14114 arg2Of µg/ml,(
R12537 T14116 T14115 arg1Of µg/ml,1
R12538 T14117 T14114 arg3Of ),(
R12539 T14119 T14118 arg2Of to,according
R12540 T14121 T14119 arg2Of schedule,to
R12541 T14121 T14120 arg1Of schedule,the
R12542 T14121 T14122 arg1Of schedule,in
R12543 T14123 T14124 arg1Of Figure,1.
R12544 T14123 T14125 arg1Of Figure,(
R12545 T14126 T14125 arg2Of G,(
R12546 T14127 T14125 arg3Of ),(
R12547 T14128 T14122 arg2Of IL-1β,in
R12548 T14128 T14123 arg1Of IL-1β,Figure
R12549 T14131 T14130 arg2Of H,(
R12550 T14132 T14130 arg3Of ),(
R12551 T14134 T14130 arg1Of levels,(
R12552 T14134 T14133 arg1Of levels,IL-8
R12553 T14134 T14135 arg1Of levels,were
R12554 T14134 T14136 arg2Of levels,measured
R12555 T14136 T14129 arg2Of measured,and
R12556 T14136 T14135 arg2Of measured,were
R12557 T14136 T14137 arg1Of measured,at
R12558 T14139 T14137 arg2Of hours,at
R12559 T14139 T14138 arg1Of hours,24
R12560 T14141 T14140 arg1Of analysis,Statistical
R12561 T14141 T14142 arg1Of analysis,was
R12562 T14141 T14143 arg2Of analysis,performed
R12563 T14143 T14142 arg2Of performed,was
R12564 T14143 T14158 arg1Of performed,and
R12565 T14144 T14143 arg3Of using,performed
R12566 T14147 T14144 arg2Of ANOVA,using
R12567 T14147 T14145 arg1Of ANOVA,two
R12568 T14147 T14146 arg1Of ANOVA,way
R12569 T14147 T14148 arg1Of ANOVA,with
R12570 T14147 T14151 arg1Of ANOVA,for
R12571 T14147 T14154 arg1Of ANOVA,*
R12572 T14147 T14156 arg1Of ANOVA,**
R12573 T14150 T14148 arg2Of correction,with
R12574 T14150 T14149 arg1Of correction,Bonferroni
R12575 T14153 T14151 arg2Of comparisons.,for
R12576 T14153 T14152 arg1Of comparisons.,multiple
R12577 T14154 T14155 arg1Of *,","
R12578 T14156 T14155 arg2Of **,","
R12579 T14158 T14157 arg1Of and,","
R12580 T14158 T14163 arg1Of and,0.05
R12581 T14158 T14165 arg1Of and,0.01
R12582 T14158 T14168 arg1Of and,0.001
R12583 T14159 T14160 arg1Of ***,signify
R12584 T14160 T14158 arg2Of signify,and
R12585 T14161 T14160 arg2Of P,signify
R12586 T14161 T14162 arg1Of P,<
R12587 T14163 T14164 arg1Of 0.05,","
R12588 T14164 T14167 arg1Of ",",and
R12589 T14165 T14164 arg2Of 0.01,","
R12590 T14167 T14166 arg1Of and,","
R12591 T14168 T14167 arg2Of 0.001,and

sentences

Id Subject Object Predicate Lexical cue
T13935 44-147 Sentence denotes NF-κB activation potentiates the degree of IL-1β production and secretion upon inflammasome activation.
T13936 148-338 Sentence denotes THP-1 reporter cells were primed overnight with heat-killed P. aeruginosa and stimulated the next day with live P. aeruginosa or additional heat-killed P. aeruginosa for the times indicated.
T13937 339-463 Sentence denotes Cell culture supernatants were assayed for (A) NF-κB/AP-1 activity, (B) IL-8, and (C) IL-1β secretion (n = 3–6 experiments).
T13938 464-620 Sentence denotes Using the same stimulation method, THP-1 reporter cells were treated with Bay11-7082 (20 µM) for 1 hour prior to priming with heat-killed PAO1 or live PAO1.
T13939 621-732 Sentence denotes Supernatants were assayed at 24 hours for (D) NF-κB/AP-1 activity, (E) IL-8, and (F) IL-1β secretion (n = 3–5).
T13940 733-1025 Sentence denotes PBMCs from CF patients (n = 11–15) and controls (n = 10–13) were treated with z-YVAD-fmk (20 µM) or Bay11-7082 (10 µM) and stimulated with live PAO1 (MOI = 1), ATP (5 mM), or Poly(dA:dT) (1 µg/ml) according to the schedule in Figure 1. (G) IL-1β and (H) IL-8 levels were measured at 24 hours.
T13941 1026-1181 Sentence denotes Statistical analysis was performed using two way ANOVA with Bonferroni correction for multiple comparisons. *, **, and *** signify P<0.05, 0.01, and 0.001.
T98 0-147 Sentence denotes 10.1371/journal.pone.0037689.g006 Figure 6 NF-κB activation potentiates the degree of IL-1β production and secretion upon inflammasome activation.
T99 148-338 Sentence denotes THP-1 reporter cells were primed overnight with heat-killed P. aeruginosa and stimulated the next day with live P. aeruginosa or additional heat-killed P. aeruginosa for the times indicated.
T100 339-463 Sentence denotes Cell culture supernatants were assayed for (A) NF-κB/AP-1 activity, (B) IL-8, and (C) IL-1β secretion (n = 3–6 experiments).
T101 464-620 Sentence denotes Using the same stimulation method, THP-1 reporter cells were treated with Bay11-7082 (20 µM) for 1 hour prior to priming with heat-killed PAO1 or live PAO1.
T102 621-732 Sentence denotes Supernatants were assayed at 24 hours for (D) NF-κB/AP-1 activity, (E) IL-8, and (F) IL-1β secretion (n = 3–5).
T103 733-1025 Sentence denotes PBMCs from CF patients (n = 11–15) and controls (n = 10–13) were treated with z-YVAD-fmk (20 µM) or Bay11-7082 (10 µM) and stimulated with live PAO1 (MOI = 1), ATP (5 mM), or Poly(dA:dT) (1 µg/ml) according to the schedule in Figure 1. (G) IL-1β and (H) IL-8 levels were measured at 24 hours.
T104 1026-1181 Sentence denotes Statistical analysis was performed using two way ANOVA with Bonferroni correction for multiple comparisons. *, **, and *** signify P<0.05, 0.01, and 0.001.